🇺🇸 FDA
Pipeline program

68-Ga PSMA11

STU-2023-0566

Phase 1 small_molecule active

Quick answer

68-Ga PSMA11 for Prostate Adenocarcinoma is a Phase 1 program (small_molecule) at Telix Pharmaceuticals Ltd with 1 ClinicalTrials.gov record(s).

Program details

Company
Telix Pharmaceuticals Ltd
Indication
Prostate Adenocarcinoma
Phase
Phase 1
Modality
small_molecule
Status
active

Clinical trials